Arteriovenous Graft
12
0
1
5
Key Insights
Highlights
Success Rate
56% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
33.3%
4 terminated out of 12 trials
55.6%
-31.0% vs benchmark
0%
0 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Optimizing Access Surgery In Senior Hemodialysis Patients
FLEX FIRST Registry Research Protocol
Validation of Arterio Venous Access Stage (AVAS) Classification
Access Creation for Hemodialysis: Association With Structural Changes of the Heart
Trial of Fistula Versus Graft in Elderly Patients
Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients
An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access
Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access
DCB for Dialysis Access Stent Graft Restenosis
A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting